SwasthyaNiketan Integrated Healthcare & Research Foundation envisions improving the quality of life of cancer patients and offering relief from pain and suffering through integrative, complementary, and holistic treatment approaches. Our aim is to research cancer medicines derived from mistletoe extract and make them easily available to support effective and compassionate integrative oncology treatment.
Cancer treatment modalities such as surgery, chemotherapy, radiotherapy, and immunotherapy often come with significant side effects, both physical and psychological. As a result, not only the patient but also the entire family is impacted physically, emotionally, and financially.
One of the latest advances in integrative cancer treatment is mistletoe extract therapy. This aligns with our mission to alleviate patients’ suffering, improve quality of life, and complement conventional treatments by reducing the side effects of modern medicine.
Why use mistletoe extracts?
- Increased effectiveness of conventional therapies when used as an adjuvant treatment
- Reduction of side effects and stimulation of the body’s innate defense mechanisms
- Potential inhibition of tumor growth and metastasis
- Reduction in pain
- Reduced recurrence rates
- Improved quality of life
Currently, this product is not manufactured in India and must be imported. As a result, many medical institutions and patients remain unaware of its potential benefits. Although approved channels exist to import the medicine, it remains inaccessible to a large section of patients because the process is cumbersome and very expensive due to logistical difficulties associated with individual imports.
Dr. Wahida Murthy and Dr. Vijayalakshmi Jayannavar, both allopathic physicians with over 35 years of clinical experience, established SwasthyaNiketan Integrated Healthcare and Research Foundation in 2020 as a Section 8 not-for-profit organization. Our initiative focuses on making this anticancer medicine affordable and easily available in India. Although the medicine has been extensively researched and used in Europe since the 20th century, it must undergo India’s regulatory procedures before it can be widely used. Accordingly, our foundation initiated this process last year by collaborating with Indian councils and research institutions to conduct research and product analysis.
Reference:
https://goetheanum.ch/en/news/mistletoe-therapy-clinically-verified
Current cancer treatments often cause significant side effects and toxicity, which necessitate innovative supportive measures such as the use of mistletoe extracts as an adjuvant therapy alongside existing treatment protocols. Therefore, research to study its role in cancer biology in India has been initiated by SwasthyaNiketan Integrated Healthcare and Research Foundation.
The objectives of this research are:
- To evaluate mistletoe extract as a potential treatment option for early stages of cancer.
- To support patients in later stages of cancer by enhancing quality of life during chemotherapy and radiotherapy.
- To investigate whether cancer in its early stages can be successfully treated with mistletoe extract as an independent therapy.
- To educate doctors and other healthcare professionals on the appropriate use of this treatment and other effective treatment options, thereby enhancing patient care, building confidence, and making treatment more cost-effective for patients.
- CSIR.IICB, Kolkata
- Bharathiyar University, Coimbatore
- Saroj Gupta Cancer Centre, Kolkata
- Medical Section Goetheanum, Dornach, Switzerland.
- Traditional Complementary Integrated Healthcare Coalition WHO, Geneva, Switzerland.
- World Goetheanum Association, Dornach, Switzerland.
- Donate: One-time or recurring contributions
- Corporate & CSR Partnerships: Join hands with us
- Spread Awareness: Share our cause within your community
